100 related articles for article (PubMed ID: 26965297)
1. Serum pentraxin 3 as a possible marker for mature cystic teratomas.
Ishida C; Iwase A; Osuka S; Goto M; Takikawa S; Nakamura T; Kotani T; Kikkawa F
Gynecol Endocrinol; 2016 Sep; 32(9):733-736. PubMed ID: 26965297
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of CA19-9 in ovarian mature cystic teratoma.
Fan JT; Yan HQ; Malla S; Fan YJ; Xu H; Li DH; Liu Y
Clin Exp Obstet Gynecol; 2016; 43(4):522-525. PubMed ID: 29734540
[TBL] [Abstract][Full Text] [Related]
3. Serum pentraxin 3 is a novel marker in Crohn's disease.
Chen J; Xu X; Xia L; Xi X; Liu B; Yang M
Mol Med Rep; 2015 Jul; 12(1):543-6. PubMed ID: 25760650
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometrioma.
Kataoka T; Watanabe Y; Hoshiai H
J Obstet Gynaecol Res; 2012 Aug; 38(8):1071-6. PubMed ID: 22568880
[TBL] [Abstract][Full Text] [Related]
5. Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
Hollan I; Bottazzi B; Cuccovillo I; Førre ØT; Mikkelsen K; Saatvedt K; Almdahl SM; Mantovani A; Meroni PL;
Arthritis Care Res (Hoboken); 2010 Mar; 62(3):378-85. PubMed ID: 20391484
[TBL] [Abstract][Full Text] [Related]
6. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
Cieślik P; Hrycek A
Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis.
Nur E; van Beers EJ; Martina S; Cuccovillo I; Otten HM; Schnog JJ; Meijers JC; Mantovani A; Brandjes DP; Bottazzi B; Biemond BJ;
Blood Cells Mol Dis; 2011 Mar; 46(3):189-94. PubMed ID: 21256776
[TBL] [Abstract][Full Text] [Related]
8. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
[TBL] [Abstract][Full Text] [Related]
9. Is There Any Relationship between Plasma Pentraxin 3 Levels and Gestational Diabetes Mellitus?
Yildirim M; Simavli SA; Uysal Derbent A; Kaygusuz I; Uysal S
Gynecol Obstet Invest; 2015; 80(4):223-7. PubMed ID: 25722060
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of the long pentraxin 3 in paracetamol-induced human acute liver injury.
Craig DG; Lee P; Pryde EA; Walker SW; Beckett GJ; Hayes PC; Simpson KJ
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):359-67. PubMed ID: 23169308
[TBL] [Abstract][Full Text] [Related]
11. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
Elshazly SA; Heiba NM; Abdelmageed WM
Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
[TBL] [Abstract][Full Text] [Related]
12. Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma.
Basta P; Mach P; Pitynski K; Bednarek W; Klimek M; Zietek J; Zajac K; Wicherek L
Neuro Endocrinol Lett; 2009 Mar; 30(1):91-8. PubMed ID: 19300397
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic implications of circulating pentraxin 3 levels in non ST-elevation acute coronary syndrome.
Eggers KM; Armstrong PW; Califf RM; Johnston N; Simoons ML; Venge P; James SK
Clin Biochem; 2013 Nov; 46(16-17):1655-9. PubMed ID: 24012697
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of plasma pentraxin 3 levels for predicting cardiac troponin elevation after percutaneous coronary intervention.
Wang Z; Sato A; Akiyama D; Kimura T; Tajiri K; Hoshi T; Sakai S; Koike A; Miyauchi T; Aonuma K
Life Sci; 2014 Jan; 95(1):40-4. PubMed ID: 24333560
[TBL] [Abstract][Full Text] [Related]
15. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations.
Yamasaki K; Kurimura M; Kasai T; Sagara M; Kodama T; Inoue K
Clin Chem Lab Med; 2009; 47(4):471-7. PubMed ID: 19327124
[TBL] [Abstract][Full Text] [Related]
16. The long pentraxin-3 is a useful marker for diagnosis of ovarian torsion: An experimental rat model.
Akman L; Erbas O; Terek MC; Aktug H; Taskiran D; Askar N
J Obstet Gynaecol; 2016; 36(3):399-402. PubMed ID: 26470829
[TBL] [Abstract][Full Text] [Related]
17. Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease.
Chang CC; Wang PH; Su PH; Lin DB; Ying TH; Yang SF; Hsieh YH
Clin Chem Lab Med; 2011 Oct; 49(10):1655-60. PubMed ID: 21679133
[TBL] [Abstract][Full Text] [Related]
18. Increased Plasma Levels of Pentraxin 3 Are Associated with Poor Prognosis of Colorectal Carcinoma Patients.
Zhang J; Wang TY; Niu XC
Tohoku J Exp Med; 2016 Sep; 240(1):39-46. PubMed ID: 27568661
[TBL] [Abstract][Full Text] [Related]
19. Pentraxin-3 as a marker of disease activity in Takayasu arteritis.
Dagna L; Salvo F; Tiraboschi M; Bozzolo EP; Franchini S; Doglioni C; Manfredi AA; Baldissera E; Sabbadini MG
Ann Intern Med; 2011 Oct; 155(7):425-33. PubMed ID: 21969341
[TBL] [Abstract][Full Text] [Related]
20. The role of pentraxin 3 as diagnostic value in classification of patients with heart failure.
Duran S; Duran I; Kaptanagası FAO; Nartop F; Ciftci H; Korkmaz GG
Clin Biochem; 2013 Aug; 46(12):983-987. PubMed ID: 23643952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
